Using Patient-Level Data to Develop Meaningful Cross-Trial Comparisons of Visual Impairment in Individuals With Diabetic Macular Edema

Advances in Therapy - United States
doi 10.1007/s12325-016-0310-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Ranibizumab in the Treatment of Patients With Visual Impairment Due to Diabetic Macular Edema

Clinical Ophthalmology
Ophthalmology
2011English

Comparative Effectiveness Trial for Diabetic Macular Edema

JAMA Ophthalmology
Ophthalmology
2015English

Review of Patient-Reported Outcomes in Diabetic Macular Edema

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Identification of Patients With Diabetic Macular Edema From Claims Data

Archives of Ophthalmology
2008English

Cost-Effectiveness of Ranibizumab Versus Aflibercept in the Treatment of Visual Impairment Due to Diabetic Macular Edema: A UK Healthcare Perspective

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2015English

Vitreoschisis in Diabetic Macular Edema

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2011English

Diabetic Macular Edema : Overview

Indian Journal of Clinical and Experimental Ophthalmology
2018English

Carotid‐cavernous Fistula in a Patient With Diabetic Macular Edema. A Case Report

Acta Ophthalmologica
MedicineOphthalmology
2018English

Responsiveness of the National Eye Institute Visual Function Questionnaire-25 to Visual Acuity Gains in Patients With Diabetic Macular Edema

Retina
MedicineOphthalmology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy